'Phosphate binders' diaporamas de présentation

New NKF-K/DOQI guidelines

New NKF-K/DOQI guidelines. Shahrzad Ossareh-M.D. Kidney Disease Outcome Quality Initiative. Definition of Chronic Kidney Disease Criteria. Kidney damage ? 3 months as defined by structural or functional abnormalities of the kidney, with or without decreased GFR, manifested by either:

799 views • 78 slides

Chapter 71

Chapter 71. Care of Patients with Acute Renal Failure and Chronic Kidney Disease. Acute Renal Failure. Pathophysiology Types of acute renal failure include: Prerenal Intrarenal Postrenal . Types of Acute Renal Failure.

957 views • 43 slides

Kidney Disease-What You Need to Know

851 views • 37 slides

Calcium & phosphor disturbance CKD- MBD

Calcium & phosphor disturbance CKD- MBD. Dr. Atapour. Phosphor. P arathyroid hormone (PTH) 1,25(OH)2D ( calcitriol ) P hosphatonins , (fibroblast growth factor 23 (FGF23) T arget organs: Bone Kidney Intestine. GFR levels below 60 mL /min GFR below 30 mL /min.

703 views • 34 slides

Selection of Phosphate Binders: New Insights

Selection of Phosphate Binders: New Insights. Program Goals. EVOLVE: Effect of Cinacalcet on CV Disease in Dialysis Patients. ADVANCE Study. INDEPENDENT Study. Closing Comments. Abbreviations. References. References (cont). References (cont).

395 views • 23 slides

Calciphylaxis AM report Lisa Rose-Jones, MD May 2, 2009

347 views • 17 slides

Calciphylaxis AM report Lisa Rose-Jones, MD May 2, 2009

181 views • 17 slides

kidney and renal diseases therapeutics market to 2017

The Kidney and Renal Diseases Therapeutics Market is Forecast to Show Moderate Growth Until 2017, it provides insights into the global kidney and renal diseases therapeutics market and market forecasts until 2017.

463 views • 5 slides

Figure 1 Hypothetical mechanisms by which phosphate binders might affect vascular calcification

126 views • 1 slides